vimarsana.com

Artificial Intelligence Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HanAll Biopharma s Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr Almira Chabi, MD, EGMP to Board of Directors

WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to announce the appointment of Dr. Almira Chabi, MD, EGMP to its Board of Directors, effective November 24, 2023. Dr. Chabi.

AI could consume as much energy as Argentina annually by 2027

China s Artificial Intelligence Programs Pose A Threat to U S National Security

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.